1. HBW Insight
  2. >>Beauty
  3. >>Policy & Regulation
  4. >>Legal

'Green' Personal Care Proving Fertile Ground For Lawsuits In US Courts – Alston & Bird Attorneys

 
• By Eileen Francis

Personal care marketers are under significant pressure to answer consumer demand for greener products and cleaner formulas, but hasty moves to keep up with the competition can attract NGO attention and potentially land companies in court.

NGOs and the class action bar are casting a wider net in their crusade against greenwashing and taking increased interest in “clean” personal care fraud, according to Alston & Bird attorneys.

“You’ve got consumers, NGOs and investors, all potentially looking at what these companies are saying,” noted Rachel Lowe, a partner in the litigation and practice group of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legal

More from Policy & Regulation

US Fragrance Firms Should Identify Domestic, Non-Tariff Sources Now – Fragrance House CEO

Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.

Cosmetics Consortium Shares Studies With FDA To Build Confidence In Animal Testing Alternatives

 
• By Lauren Nardella

By guiding regulators through case studies and mock dossier examples of how to utilize new approach methodologies, the International Collaboration on Cosmetics Safety hopes to counter hesitations in replacing animal tests.

Stakeholders Hope US FDA’s Proposed Animal Test Phase-Out For Drugs Will Extend To OTCs, Cosmetics

 
• By Eileen Francis and Lauren Nardella

The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.